Compliance Informed Consent World Health 
HIPAA Journal
JANUARY 16, 2023
Although specific concerns differ by organization, the concerns can generally be categorized as informed consent to use data, safety and transparency, algorithmic fairness, and data privacy. . These concerns are not unique to the United States nor to the healthcare industry.
SQA
APRIL 30, 2021
generic, biosimilar, or hybrid application), informed consent is irrelevant provided that both applications relate to a medicinal product with the same qualitative and quantitative composition in active substances and the same pharmaceutical form. World Health Organization (WHO).
SQA
FEBRUARY 15, 2023
A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. The electronic certificate and the paper version are equally authentic.
Expert insights. Personalized for you.
68 
Let's personalize your content